Rothia mucilaginosa Pneumonia Diagnosed by Quantitative Cultures and Intracellular Organisms of Bronchoalveolar Lavage in a Lymphoma Patient
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Rothia mucilaginosa is a gram-positive coccus of the family Micrococcaceae. R. mucilaginosa is considered a part of the normal flora of the human oropharynx and upper respiratory tract and lower respiratory tract infections attributable to R. mucilaginosa are not frequent. We present a case of pneumonia, in which the R. mucilaginosa infection was diagnosed by quantitative cultures of a bronchoalveolar lavage (BAL) specimen. A 46-yr-old woman with B lymphoblastic lymphoma was admitted to the hospital for scheduled chemotherapy. Her chest computed tomography (CT) scan revealed bilateral multifocal nodular and patchy consolidation in both lungs. Investigation of the BAL specimen revealed that 7% of leukocytes had intracellular gram-positive cocci. The quantitative cultures of the BAL specimen grew mucoid, non-hemolytic, and grayish convex colonies on blood agar at a count of approximately 200,000 colony-forming units/mL. The colonies were identified as R. mucilaginosa. The patient was empirically treated with levofloxacin for 7 days, after which findings on the chest radiograph and CT scan improved. She was discharged with improvement on hospital day 46. To our knowledge, this is the first report of R. mucilaginosa pneumonia diagnosed in Korea. Quantitative culture of BAL specimen and examination of intracellular organisms are crucial for assessing the clinical significance of R. mucilaginosa recovered from the lower respiratory tract.
Abstract
Rothia mucilaginosa is a gram-positive coccus of the family Micrococcaceae. R. mucilaginosa is considered a part of the normal flora of the human oropharynx and upper respiratory tract and lower respiratory tract infections attributable to R. mucilaginosa are not frequent. We present a case of pneumonia, in which the R. mucilaginosa infection was diagnosed by quantitative cultures of a bronchoalveolar lavage (BAL) specimen. A 46-yr-old woman with B lymphoblastic lymphoma was admitted to the hospital for scheduled chemotherapy. Her chest computed tomography (CT) scan revealed bilateral multifocal nodular and patchy consolidation in both lungs. Investigation of the BAL specimen revealed that 7% of leukocytes had intracellular gram-positive cocci. The quantitative cultures of the BAL specimen grew mucoid, non-hemolytic, and grayish convex colonies on blood agar at a count of approximately 200,000 colony-forming units/mL. The colonies were identified as R. mucilaginosa. The patient was empirically treated with levofloxacin for 7 days, after which findings on the chest radiograph and CT scan improved. She was discharged with improvement on hospital day 46. To our knowledge, this is the first report of R. mucilaginosa pneumonia diagnosed in Korea. Quantitative culture of BAL specimen and examination of intracellular organisms are crucial for assessing the clinical significance of R. mucilaginosa recovered from the lower respiratory tract.
참고문헌 (24)
- Becker K, "Staphylococcus, Micrococcus and other catalase- positive cocci, In Manual of clinical microbiology. 10th ed", pp.308~330 (2011), American Society for Microbiology
- Rubin SJ, "Endocarditis associated with cardiac catheterization due to a Gram-positive coccus designated Micrococcus mucilaginosus incertae sedis", J Clin Microbiol, 7, pp.546~549 (1978)
- Faiad G, "Rothia mucilaginosa life threatening infections in non-neutropenic hosts", Open Journal of Internal Medicine, 1, pp.68~71 (2011)
- Ascher DP, "Infections due to Stomatococcus mucilaginosus: 10 cases and review", Rev Infect Dis, 13, pp.1048~1052 (1991)
- Treviño M, "Stomatococcus mucilaginosus septicemia in a patient with acute lymphoblastic leukaemia", Eur J Clin Microbiol Infect Dis, 17, pp.505~507 (1998)
- Korsholm TL, "Eight cases of lower respiratory tract infection caused by Stomatococcus mucilaginosus", Scand J Infect Dis, 39, pp.913~917 (2007)
- Lambotte O, "Pneumonia due to Stomatococcus mucilaginosus in an AIDS patient: case report and literature review", Clin Microbiol Infect, 5, pp.112~114 (1999)
- Sánchez-Carrillo C, "Stomatococcus mucilaginosus pneumonia in a liver-transplant patient", Clin Microbiol Newsl, 16, pp.150~151 (1995)
- Cunniffe JG, "Stomatococcus mucilaginosus lower respiratory tract infection in a patient with AIDS", J Infect, 29, pp.327~330 (1994)
- Clinical Laboratory Standards Institute, "Methods for antimicrobial dilution and disk susceptibility testing of infrequently isolated or fastidious bacteria; Approved guideline 2nd ed, M45-A2", pp.18~19 (2010), Clinical Laboratory Standards Institute
- Cantral DE, "Quantitative culture of bronchoalveolar lavage fluid for the diagnosis of bacterial pneumonia", Am J Med, 95, pp.601~607 (1993)
- Allaouchiche B, "Early diagnosis of ventilator-associated pneumonia. Is it possible to define a cutoff value of infected cells in BAL fluid?", Chest, 110, pp.1558~1565 (1996)
- Torres A, "Value of intracellular bacteria detection in the diagnosis of ventilator associated pneumonia", Thorax, 51, pp.378~384 (1996)
- Solé-Violán J, "Usefulness of microscopic examination of intracellular organisms in lavage fluid in ventilator-associated pneumonia", Chest, 106, pp.889~894 (1994)
- Horan TC, "CDC", NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting, 2008, pp.36, 309~332
- Garcia LS, "Clinical microbiology procedures handbook. 3rd ed, 1" (2010), ASM Press
- von Eiff C, "Antimicrobial susceptibilities of Stomatococcus mucilaginosus and of Micrococcus spp", Antimicrob Agents Chemother, 39, pp.268~270 (1995)
- von Eiff C, "In vitro activity of ciprofloxacin, ofloxacin, and levofloxacin against Micrococcus species and Stomatococcus mucilaginosus isolated from healthy subjects and neutropenic patients", Eur J Clin Microbiol Infect Dis, 17, pp.890~892 (1998)
- Skogen PG, "Bactericidal activity in cerebrospinal fluid by treating meningitis caused by Stomatococcus mucilaginosus with rifampicin, cefotaxime and vancomycin in a neutropenic child", Clin Microbiol Infect, 7, pp.39~42 (2001)
- McWhinney PH, "Stomatococcus mucilaginosus: an emerging pathogen in neutropenic patients", Clin Infect Dis, 14, pp.641~646 (1992)
- Chomarat M, "Susceptibility to aminoglycosides of 63 strains of Stomatococcus mucilaginosus isolated from sputum", Zentralbl Bakteriol, 276, pp.63~67 (1991)
- Clinical Laboratory Standards Institute, "Performance standards for antimicrobial susceptibility testing. Twenty-Second Informational supplement, M100-S22", pp.70~79 (2012), Clinical Laboratory Standards Institute
- Capitano B, "Steady-state intrapulmonary concentrations of moxifloxacin, levofloxacin, and azithromycin in older adults", Chest, 125, pp.965~973 (2004)
- Zhanel GG, "A critical review of the fluoroquinolones: focus on respiratory infections", Drugs, 62, pp.13~59 (2002)